Multi-Layered Mechanisms of Immunological Tolerance at the Maternal-Fetal Interface

키워드

참고문헌 (111)

1. Moffett A, "The immunological paradox of pregnancy : a reappraisal", Placenta, 25, pp.1~8 (2004)
2. Billingham RE, "Actively acquired tolerance of foreign cells", Nature, 172, pp.603~606 (1953)
3. Woodruff MF, "Transplantation immunity and the immunological problem of pregnancy", Proc R Soc Lond B Biol Sci, 148, pp.68~75 (1958)
4. Beer AE, "Implantation, transplantation, and epithelial-mesenchymal relationships in the rat uterus", J Exp Med, 132, pp.721~736 (1970)
5. Bowman JM, "The prevention of Rh immunization", Transfus Med Rev, 2, pp.129~150 (1988)
6. Girardi G, "Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction", J Exp Med, 203, pp.2165~2175 (2006)
7. McKelvey KJ, "Embryonic", fetal mortality and intrauterine growth restriction is not exclusive to the CBA, Sci Rep, pp.2016, 6[DOI]
8. Petitbarat M, "Critical role and therapeutic control of the lectin pathway of complement activation in an abortion-prone mouse mating", J Immunol, 195, pp.5602~5607 (2015)
9. Jin LP, "Blockade of CD80 and CD86 at the time of implantation inhibits maternal rejection to the allogeneic fetus in abortion-prone matings", J Reprod Immunol, 65, pp.133~146 (2005)
10. Erlebacher A, "Constraints in antigen presentation severely restrict T cell recognition of the allogeneic fetus", J Clin Invest, 117, pp.1399~1411 (2007)
11. Tay CS, "Cis-acting pathways selectively enforce the non-immunogenicity of shed placental antigen for maternal CD8 T cells", PLoS One, 8, pp.e84064~ (2013)
12. Perchellet AL, "Maternal CD4+ and CD8+ T cell tolerance towards a fetal minor histocompatibility antigen in T cell receptor transgenic mice", Biol Reprod, 89, pp.102~ (2013)
13. Kahn DA, "Pregnancy induces a fetal antigen-specific maternal T regulatory cell response that contributes to tolerance", Proc Natl Acad Sci U S A, 107, pp.9299~9304 (2010)
14. Soares MJ, "Hemochorial placentation : development, function, and adaptations", Biol Reprod, 99, pp.196~211 (2018)
15. Tetro N, "The placental barrier : the gate and the fate in drug distribution", Pharm Res, 35, pp.71~ (2018)
16. Billington WD, "Placental barrier to maternal cells", Nature, 224, pp.704~706 (1969)
17. Tuffrey M, "Porosity of the mouse placenta to maternal cells", Nature, 221, pp.1029~1030 (1969)
18. Hunziker RD, "Placenta as a selective barrier to cellular traffic", J Immunol, 133, pp.667~671 (1984)
19. Zhou L, "Two independent pathways of maternal cell transmission to offspring : through placenta during pregnancy and by breast-feeding after birth", Immunology, 101, pp.570~580 (2000)
20. Sargent IL, "Maternal cell-mediated sensitisation to paternal HLA may occur, but is not a regular event in normal human pregnancy", J Reprod Immunol, 10, pp.111~120 (1987)
21. Wegmann TG, "Pregnant mice are not primed but can be primed to fetal alloantigens", Proc Natl Acad Sci U S A, 76, pp.2410~2414 (1979)
22. Saito M, "Immune reactivity of allogeneically pregnant mice to paternal MHC antigens on fetal and placental cells assessed by second set rejection of ascites tumor cells", J Reprod Immunol, 8, pp.139~151 (1985)
23. Wegmann TG, "Allogeneic placenta is a paternal strain antigen immunoabsorbent", J Immunol, 122, pp.270~274 (1979)
24. Wegmann TG, "The ability of the murine placenta to absorb monoclonal anti-fetal H-2K antibody from the maternal circulation", J Immunol, 123, pp.1020~1023 (1979)
25. Ishii M, "Expression of functional chemokine receptors of human placental cells", Am J Reprod Immunol, 44, pp.365~373 (2000)
26. Martinez de la Torre Y, "Protection against inflammation-and autoantibody-caused fetal loss by the chemokine decoy receptor D6", Proc Natl Acad Sci U S A, 104, pp.2319~2324 (2007)
27. Teoh PJ, "Atypical chemokine receptor ACKR2 mediates chemokine scavenging by primary human trophoblasts and can regulate fetal growth, placental structure, and neonatal mortality in mice", J Immunol, 193, pp.5218~5228 (2014)
28. Lee KM, "Placental chemokine compartmentalisation : a novel mammalian molecular control mechanism", PLoS Biol, 17, pp.e3000287~ (2019)
29. Nancy P, "Chemokine gene silencing in decidual stromal cells limits T cell access to the maternal-fetal interface", Science, 336, pp.1317~1321 (2012)
30. Tersigni C, "Placental chemokine receptor D6 is functionally impaired in pre-eclampsia", PLoS One, 11, pp.e0164747~ (2016)
31. Usta A, "Placental fractalkine immunoreactivity in preeclampsia and its correlation with histopathological changes in the placenta and adverse pregnancy outcomes", J Matern Fetal Neonatal Med, 33, pp.806~815 (2020)
32. Neefjes J, "Towards a systems understanding of MHC class I and MHC class II antigen presentation", Nat Rev Immunol, 11, pp.823~836 (2011)
33. Afzali B, "Pathways of major histocompatibility complex allorecognition", Curr Opin Organ Transplant, 13, pp.438~444 (2008)
34. Wei XH, "Differential expression of HLA-E, HLA-F, and HLA-G transcripts in human tissue", Hum Immunol, 29, pp.131~142 (1990)
35. Redline RW, "Localization of fetal major histocompatibility complex antigens and maternal leukocytes in murine placenta. Implications for maternal-fetal immunological relationship", Lab Invest, 61, pp.27~36 (1989)
36. Apps R, "A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1", Eur J Immunol, 37, pp.1924~1937 (2007)
37. Ristich V, "Tolerization of dendritic cells by HLA-G", Eur J Immunol, 35, pp.1133~1142 (2005)
38. Faure M, "KIR2DL4(CD158d), an NK cell-activating receptor with inhibitory potential", J Immunol, 168, pp.6208~6214 (2002)
39. Sharkey AM, "Killer Ig-like receptor expression in uterine NK cells is biased toward recognition of HLA-C and alters with gestational age", J Immunol, 181, pp.39~46 (2008)
40. Hiby SE, "Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2", J Clin Invest, 120, pp.4102~4110 (2010)
41. Li Q, "ELF3 activated by a superenhancer and an autoregulatory feedback loop is required for high-level HLA-C expression on extravillous trophoblasts", Proc Natl Acad Sci U S A, 118, pp.e2025512118~ (2021)
42. Yie SM, "HLA-G protein concentrations in maternal serum and placental tissue are decreased in preeclampsia", Am J Obstet Gynecol, 191, pp.525~529 (2004)
43. Wang Q, "Single-cell transcriptional profiling reveals cellular and molecular divergence in human maternal-fetal interface", Sci Rep, 12, pp.10892~ (2022)
44. Murphy SP, "Absence of MHC class II antigen expression in trophoblast cells results from a lack of class II transactivator(CIITA)gene expression", Mol Reprod Dev, 51, pp.1~12 (1998)
45. van den Elsen PJ, "Lack of CIITA expression is central to the absence of antigen presentation functions of trophoblast cells and is caused by methylation of the IFN-γ inducible promoter(PIV)of CIITA", Hum Immunol, 61, pp.850~862 (2000)
46. Holtz R, "Class II transactivator(CIITA)promoter methylation does not correlate with silencing of CIITA transcription in trophoblasts", Biol Reprod, 69, pp.915~924 (2003)
47. Athanassakis-Vassiliadis I, "Induction of class II MHC antigen expression on the murine placenta by 5-azacytidine correlates with fetal abortion", Cell Immunol, 128, pp.438~449 (1990)
48. Shima T, "Uterine CD11c+ cells induce the development of paternal antigen-specific Tregs via seminal plasma priming", J Reprod Immunol, 141, pp.103165~ (2020)
49. Collins MK, "Dendritic cell entrapment within the pregnant uterus inhibits immune surveillance of the maternal", fetal interface in mice, 2009, pp.119, 2062~2073
50. Einenkel R, "Hormonally controlled ILC antigen presentation potential is reduced during pregnancy", Reproduction, 160, pp.155~169 (2020)
51. Bulmer JN, "Granulated lymphocytes in human endometrium : histochemical and immunohistochemical studies", Hum Reprod, 6, pp.791~798 (1991)
52. Han M, "IL-21R-STAT3 signalling initiates a differentiation program in uterine tissue-resident NK cells to support pregnancy", Nat Commun, 14, pp.7109~ (2023)
53. Koopman LA, "Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential", J Exp Med, 198, pp.1201~1212 (2003)
54. Pende D, "HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex", Eur J Immunol, 27, pp.1875~1880 (1997)
55. Tayade C, "Differential transcription of Eomes and T-bet during maturation of mouse uterine natural killer cells", J Leukoc Biol, 78, pp.1347~1355 (2005)
56. Söderström K, "CD94", NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells, 1997, pp.159, 1072~1075
57. Rajagopalan S, "A human histocompatibility leukocyte antigen(HLA)-G-specific receptor expressed on all natural killer cells", J Exp Med, 189, pp.1093~1100 (1999)
58. Colonna M, "A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells", J Exp Med, 186, pp.1809~1818 (1997)
59. Clark MM, "Human birth weight and reproductive immunology : Testing for interactions between maternal and offspring KIR and HLA-C genes", Hum Hered, 81, pp.181~193 (2016)
60. Xiong S, "Maternal uterine NK cell-activating receptor KIR2DS1 enhances placentation", J Clin Invest, 123, pp.4264~4272 (2013)
61. Fu B, "Natural killer cells promote immune tolerance by regulating inflammatory TH17 cells at the human maternal-fetal interface", Proc Natl Acad Sci U S A, 110, pp.E231~ (2013)
62. Rowe JH, "Pregnancy imprints regulatory memory that sustains anergy to fetal antigen", Nature, 490, pp.102~106 (2012)
63. Aluvihare VR, "Regulatory T cells mediate maternal tolerance to the fetus", Nat Immunol, 5, pp.266~271 (2004)
64. Samstein RM, "Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict", Cell, 150, pp.29~38 (2012)
65. Lee JB, "Immune checkpoint inhibitors in 10 years : contribution of basic research and clinical application in cancer immunotherapy", Immune Netw, 22, pp.e2~ (2022)
66. Tekguc M, "Treg-expressed CTLA-4 depletes CD80", CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells, 2021, pp.118, e2023739118~
67. Gianchecchi E, "Inhibitory receptors and pathways of lymphocytes : The role of PD-1 in Treg development and their involvement in autoimmunity onset and cancer progression", Front Immunol, 9, pp.2374~ (2018)
68. Huang CT, "Role of LAG-3 in regulatory T cells", Immunity, 21, pp.503~513 (2004)
69. Takahashi T, "Immunologic self-tolerance maintained by CD25(+)CD4(+)regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4", J Exp Med, 192, pp.303~310 (2000)
70. Lee GR, "Molecular mechanisms of T helper cell differentiation and functional specialization", Immune Netw, 23, pp.e4~ (2023)
71. Raimondi G, "Regulated compartmentalization of programmed cell death-1 discriminates CD4+CD25+ resting regulatory T cells from activated T cells", J Immunol, 176, pp.2808~2816 (2006)
72. Sasaki Y, "Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases", Mol Hum Reprod, 10, pp.347~353 (2004)
73. Meggyes M, "The importance of the PD-1", PD-L1 pathway at the maternal-fetal interface, 2019, pp.19, 74~
74. Oida T, "TGF-β-mediated suppression by CD4+CD25+ T cells is facilitated by CTLA-4 signaling", J Immunol, 177, pp.2331~2339 (2006)
75. Lin Y, "Prevention of CpG-induced pregnancy disruption by adoptive transfer of in vitro-induced regulatory T cells", PLoS One, 9, pp.e94702~ (2014)
76. Oliver MA, "TGFβ macrophage reprogramming : a new dimension of macrophage plasticity", J Leukoc Biol, 115, pp.411~414 (2024)
77. Hsu P, "IL-10 potentiates differentiation of human induced regulatory T cells via STAT3 and Foxo1", J Immunol, 195, pp.3665~3674 (2015)
78. Arruvito L, "Expansion of CD4+CD25+and FOXP3+ regulatory T cells during the follicular phase of the menstrual cycle : implications for human reproduction", J Immunol, 178, pp.2572~2578 (2007)
79. Geng X, "Downregulation of miR-33a", b and miR-181a contributes to recurrent pregnancy loss by upregulating S1PR1 and repressing regulatory T cell differentiation, 2022, pp.121, 137~144
80. Cai S, "The effectiveness and safety of intrauterine infusion of autologous regulatory T cells(Tregs)in patients with recurrent pregnancy loss and low levels of endometrial FoxP3+ cells : a retrospective cohort study", Am J Reprod Immunol, 90, pp.e13735~ (2023)
81. Shepard MT, "PD-1 regulates T cell proliferation in a tissue and subset-specific manner during normal mouse pregnancy", Immunol Invest, 42, pp.385~408 (2013)
82. Wang SC, "PD-1 and Tim-3 pathways are associated with regulatory CD8+ T-cell function in decidua and maintenance of normal pregnancy", Cell Death Dis, 6, pp.e1738~ (2015)
83. Vento-Tormo R, "Single-cell reconstruction of the early maternal-fetal interface in humans", Nature, 563, pp.347~353 (2018)
84. Wang S, "Excessive immune activation and the correlation with decreased expression of PD-1 at the maternal-fetal interface in preeclampsia", Reprod Sci, 30, pp.192~202 (2023)
85. Jin LP, "The CD4+CD25 bright regulatory T cells and CTLA-4 expression in peripheral and decidual lymphocytes are down-regulated in human miscarriage", Clin Immunol, 133, pp.402~410 (2009)
86. Whyte A, "Increased sialylation of surface glycopeptides of human trophoblast compared with fetal cells from the same conceptus", J Exp Med, 148, pp.1087~1092 (1978)
87. Chen Q, "Evidence for differential glycosylation of trophoblast cell types", Mol Cell Proteomics, 15, pp.1857~1866 (2016)
88. Abeln M, "Sialic acid is a critical fetal defense against maternal complement attack", J Clin Invest, 129, pp.422~436 (2019)
89. Rizzuto G, "Establishment of fetomaternal tolerance through glycan-mediated B cell suppression", Nature, 603, pp.497~502 (2022)
90. Vijayan M, "Decidual glycodelin-A polarizes human monocytes into a decidual macrophage-like phenotype through Siglec-7", J Cell Sci, 133, pp.jcs244400~ (2020)
91. Hwu P, "Indoleamine 2, 3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation", J Immunol, 164, pp.3596~3599 (2000)
92. Fallarino F, "The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells", J Immunol, 176, pp.6752~6761 (2006)
93. Mezrich JD, "An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells", J Immunol, 185, pp.3190~3198 (2010)
94. Munn DH, "Prevention of allogeneic fetal rejection by tryptophan catabolism", Science, 281, pp.1191~1193 (1998)
95. Kudo Y, "Indoleamine 2, 3-dioxygenase : distribution and function in the developing human placenta", J Reprod Immunol, 61, pp.87~98 (2004)
96. Hönig A, "Indoleamine 2, 3-dioxygenase(IDO)expression in invasive extravillous trophoblast supports role of the enzyme for materno-fetal tolerance", J Reprod Immunol, 61, pp.79~86 (2004)
97. Baban B, "Indoleamine 2, 3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific", J Reprod Immunol, 61, pp.67~77 (2004)
98. Lee JH, "Progesterone promotes differentiation of human cord blood fetal T cells into T regulatory cells but suppresses their differentiation into Th17 cells", J Immunol, 187, pp.1778~1787 (2011)
99. Fu B, "TH17 cells in human recurrent pregnancy loss and pre-eclampsia", Cell Mol Immunol, 11, pp.564~570 (2014)
100. Wang F, "Progesterone-mediated remodeling of the maternal-fetal interface by a PGRMC1-dependent mechanism", J Reprod Immunol, 163, pp.104244~ (2024)
101. Schumacher A, "Human chorionic gonadotropin-mediated immune responses that facilitate embryo implantation and placentation", Front Immunol, 10, pp.2896~ (2019)
102. Zhu JY, "Regulation of trophoblast invasion : the role of matrix metalloproteinases", Rev Obstet Gynecol, 5, pp.e137~ (2012)
103. Quintero-Fabián S, "Role of matrix metalloproteinases in angiogenesis and cancer", Front Oncol, 9, pp.1370~ (2019)
104. Matjila M, "The differential expression of Kiss1, MMP9 and angiogenic regulators across the feto-maternal interface of healthy human pregnancies : implications for trophoblast invasion and vessel development", PLoS One, 8, pp.e63574~ (2013)
105. Ferrara N, "VEGF and the quest for tumour angiogenesis factors", Nat Rev Cancer, 2, pp.795~803 (2002)
106. Wang J, "Targeting MHC-I inhibitory pathways for cancer immunotherapy", Trends Immunol, 45, pp.177~187 (2024)
107. Tanaka A, "Regulatory T cells in cancer immunotherapy", Cell Res, 27, pp.109~118 (2017)
108. Crosley EJ, "Placental invasion, preeclampsia risk and adaptive molecular evolution at the origin of the great apes : evidence from genome-wide analyses", Placenta, 34, pp.127~132 (2013)
109. Kshitiz AJ, "Evolution of placental invasion and cancer metastasis are causally linked", Nat Ecol Evol, 3, pp.1743~1753 (2019)
110. Sivori S, "Inhibitory receptors and checkpoints in human NK cells, implications for the immunotherapy of cancer", Front Immunol, 11, pp.2156~ (2020)
111. Liu M, "Targeting the IDO1 pathway in cancer : from bench to bedside", J Hematol Oncol, 11, pp.100~ (2018)

관련 논문AI추천